Treace Medical Concepts, Inc. (TMCI)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Treace Medical Concepts, Inc. (TMCI) is up 41.6% since the beginning of the year. At $3 per share, TMCI is trading 55.4% below its 52-week high of $8. Investors who bought $1,000 worth of TMCI shares 5 years ago would now be looking at an investment worth $96.

Treace Medical Concepts, Inc. (TMCI) has returned 41.63% so far this year and -39.55% over the past 12 months.

Based on dividend-adjusted daily data since Apr 23, 2021, TMCI's average daily return is -0.03%, while the average monthly return is -0.56%.

Historically, 38% of months were positive and 62% were negative. The best month was May 2026 with a return of +91.2%, while the worst month was Nov 2025 at -53.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.

On a daily basis, TMCI closed higher 47% of trading days. The best single day was Nov 6, 2024 with a return of +35.1%, while the worst single day was May 8, 2024 at -62.5%.

Treace Medical Concepts, Inc. has an annualized alpha of -22.29%, beta of 1.36, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since April 26, 2021.

• This stock participated in 198.77% of S&P 500 Index downside but only 30.40% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

TMCI ranks 23 for risk / return — below 23% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Treace Medical Concepts, Inc. (TMCI) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Treace Medical Concepts, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Treace Medical Concepts, Inc. was 96.68%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current Treace Medical Concepts, Inc. drawdown is 90.39%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Treace Medical Concepts, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Treace Medical Concepts, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.